SEC EDGAR Filing Information

Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend]

Filing Date Changed: 2009-04-03
Documents: 2

SEC Accession No.
0000903423-09-000316
Filing date: 2009-04-03
Accepted: 2009-04-03 16:08:32

Table of submitted documents:

Seq	Type	Document	Size	Description
1	SC 13D/A	eastbourne-13da4_0403.htm	18080
2	EX-99.F	eastbourne-13da4ex99f_0403.htm	14083

		0000903423-09-000316.txt	34112	Complete submission text file

Filer Information:

AMYLIN PHARMACEUTICALS INC (Subject) (0000881464)
IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42168 | Film No.: 09732215
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
9360 TOWNE CENTRE DR
SUITE 110
SAN DIEGO CA 92121
6195522200

Mailing Address
9360 TOWNE CENTRE DR
SUITE 110
SAN DIEGO CA 92121

EASTBOURNE CAPITAL MANAGEMENT LLC/CA (Filed by) (0001140888)
IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A | Act: | Film No.:

Business Address
1101 FIFTH AVENUE
SUITE 370
SAN RAFAEL CA 94901
4154481200

Mailing Address
1101 FIFTH AVENUE
SUITE 370
SAN RAFAEL CA 94901